Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tranilast in Medium to Large Volume Benign Prostatic Hyperplasia
NCT06689514Phase 1Recruiting
- Start
- Jan 2025
- Primary completion
- Dec 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised trial of tranilast in benign prostatic hyperplasia (BPH) (3 arms). Primary endpoint: Prostate volume at 6 months. Started Jan 2025; status: recruiting.
02
Drugs
tranilast
03
Conditions
benign prostatic hyperplasia (BPH)
Beyond the preview
Go deeper on NCT06689514.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06689514.